Muscle power in children, youth and young adults who acquired HIV perinatally

Η Μ Macdonald1, L Nettlefold, E J Maan

  • 1Department of Family Practice, University of British Columbia, Vancouver, Canada.

Insights

Youth with perinatally acquired HIV show small deficits in muscle power compared to HIV-unexposed uninfected youth. These power deficits remained stable over two years, indicating a need for interventions to improve muscle function.

Area of Science:

  • Pediatric endocrinology
  • HIV/AIDS research
  • Sports medicine

Background:

  • Perinatal HIV infection can impact growth and development.
  • Muscle function is crucial for overall health and physical activity in youth.

Purpose of the Study:

  • To compare muscle power in youth with perinatal HIV infection versus HIV-unexposed uninfected (HUU) youth.
  • To assess changes in muscle power over a 24-month period.

Main Methods:

  • Assessed muscle power, force, efficiency, jump height, and velocity using a force platform in HIV+ youth and HUU controls.
  • Adjusted for height and muscle cross-sectional area (MCSA) in statistical analyses.
  • Longitudinal follow-up at 12 and 24 months.

Main Results:

  • HIV+ youth exhibited lower muscle power (Pmax/mass), force (Fmax/BW), and velocity (Vmax) compared to HUU controls at baseline.
  • Muscle power deficits were associated with immunosuppression but not after adjusting for height and MCSA.
  • Muscle power outcomes remained stable over the 24-month study period.

Conclusions:

  • Children and youth with perinatally acquired HIV demonstrate subtle deficits in muscle power.
  • Muscle power trajectories are stable over two years in this population.
  • Further research is required to develop strategies for enhancing dynamic muscle function in youth with HIV.
Abstract

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.4K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
338
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
293
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K